Genmab AS Correlations

GMAB Stock  USD 20.80  0.29  1.41%   
The current 90-days correlation between Genmab AS and Ascendis Pharma AS is -0.09 (i.e., Good diversification). The correlation of Genmab AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Genmab AS Correlation With Market

Significant diversification

The correlation between Genmab AS and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.

Moving against Genmab Stock

  0.44DNLI Denali TherapeuticsPairCorr
  0.44DRUG Bright Minds BiosciencesPairCorr
  0.42VCYT VeracytePairCorr
  0.42VERA Vera TherapeuticsPairCorr
  0.39A Agilent TechnologiesPairCorr
  0.37VCEL Vericel Corp OrdPairCorr
  0.34VERV Verve TherapeuticsPairCorr
  0.51VRDN Viridian TherapeuticsPairCorr
  0.42ELDN Eledon PharmaceuticalsPairCorr
  0.39VXRT Vaxart IncPairCorr
  0.37VYGR Voyager TherapeuticsPairCorr
  0.35ELAN Elanco Animal HealthPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
TERNAPLS
LEGNAKRO
AMLXAPLS
TERNAMLX
DAWNBPMC
DAWNAPLS
  
High negative correlations   
BPMCASND
DAWNASND
AKROAPLS
TERNAKRO
AMLXAKRO
DAWNAKRO

Risk-Adjusted Indicators

There is a big difference between Genmab Stock performing well and Genmab AS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genmab AS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ASND  2.49  0.46  0.20  0.85  2.21 
 8.41 
 18.15 
APLS  2.15 (0.37) 0.00 (0.46) 0.00 
 4.11 
 20.77 
BGNE  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
AKRO  4.54  1.46  0.41  0.72  2.82 
 5.13 
 104.81 
BPMC  2.15  0.14  0.06  0.06  2.59 
 5.87 
 26.30 
DAWN  3.03 (0.51) 0.00 (1.79) 0.00 
 6.77 
 22.86 
MRTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
AMLX  3.67  0.02  0.02 (1.01) 5.12 
 7.20 
 21.45 
TERN  3.07 (0.92) 0.00 (1.26) 0.00 
 5.03 
 20.46 
LEGN  2.39  0.22  0.11 (2.17) 2.61 
 6.73 
 14.84 

Genmab AS Corporate Executives

Elected by the shareholders, the Genmab AS's board of directors comprises two types of representatives: Genmab AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genmab. The board's role is to monitor Genmab AS's management team and ensure that shareholders' interests are well served. Genmab AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genmab AS's outside directors are responsible for providing unbiased perspectives on the board's policies.